Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126810531 | 12681053 | 1 | I | 20160822 | 20160824 | 20160824 | PER | PHEH2016US021209 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160824 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126810531 | 12681053 | 1 | PS | FEMARA | LETROZOLE | 1 | Oral | 1 DF, QD (01 PILL) | U | 20726 | 1 | DF | TABLET | QD | |||||
126810531 | 12681053 | 2 | C | Melatonin | MELATONIN | 1 | Oral | U | 0 | ||||||||||
126810531 | 12681053 | 3 | C | MULTI VIT | 2 | Oral | U | 0 | |||||||||||
126810531 | 12681053 | 4 | C | ASHWAGANDHA | HERBALS | 1 | Oral | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126810531 | 12681053 | 1 | Product used for unknown indication |
126810531 | 12681053 | 2 | Insomnia |
126810531 | 12681053 | 3 | Product used for unknown indication |
126810531 | 12681053 | 4 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126810531 | 12681053 | Fatigue | |
126810531 | 12681053 | Muscular weakness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |